241 related articles for article (PubMed ID: 35769483)
1. Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Immunotherapy in Gastric Cancer.
Song J; Wei R; Huo S; Gao J; Liu X
Front Immunol; 2022; 13():920512. PubMed ID: 35769483
[TBL] [Abstract][Full Text] [Related]
2. Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Chemotherapy in Acute Myeloid Leukemia.
Qu S; Huang X; Guo X; Zheng Z; Wei T; Chen B
Drug Des Devel Ther; 2023; 17():1651-1663. PubMed ID: 37305402
[TBL] [Abstract][Full Text] [Related]
3. Transcriptomic characterization and construction of M2 macrophage-related prognostic and immunotherapeutic signature in ovarian metastasis of gastric cancer.
Gao J; Zhao Z; Zhang H; Huang S; Xu M; Pan H
Cancer Immunol Immunother; 2023 May; 72(5):1121-1138. PubMed ID: 36336725
[TBL] [Abstract][Full Text] [Related]
4. Construction of ovarian metastasis-related immune signature predicting prognosis of gastric cancer patients.
Gao J; Huo S; Zhang Y; Zhao Z; Pan H; Liu X
Cancer Med; 2023 Jan; 12(1):913-929. PubMed ID: 35621244
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of biomarkers for epithelial-mesenchymal transition-related cells to estimate the prognosis and immune microenvironment in primary gastric cancer by the integrated analysis of single-cell and bulk RNA sequencing data.
Shen K; Ke S; Chen B; Zhang T; Wang H; Lv J; Gao W
Math Biosci Eng; 2023 Jun; 20(8):13798-13823. PubMed ID: 37679111
[TBL] [Abstract][Full Text] [Related]
6. Gastric cancer peritoneal metastasis related signature predicts prognosis and sensitivity to immunotherapy in gastric cancer.
Sun Y; Chen Y; Zhuang W; Fang S; Chen Q; Lian M; Lv C; Weng J; Wei R; Lin Y; Cai L; Wang Q
J Cell Mol Med; 2023 Nov; 27(22):3578-3590. PubMed ID: 37605453
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT.
Wang R; Sun Y; Yu W; Yan Y; Qiao M; Jiang R; Guan W; Wang L
J Exp Clin Cancer Res; 2019 Jan; 38(1):20. PubMed ID: 30646925
[TBL] [Abstract][Full Text] [Related]
8. Integrated analysis of single-cell and bulk RNA-sequencing reveals a novel signature based on NK cell marker genes to predict prognosis and immunotherapy response in gastric cancer.
Sun JR; Kong CF; Ye YX; Wang Q; Qu XK; Jia LQ; Wu S
Sci Rep; 2024 Apr; 14(1):7648. PubMed ID: 38561388
[TBL] [Abstract][Full Text] [Related]
9. Five EMT-related genes signature predicts overall survival and immune environment in microsatellite instability-high gastric cancer.
Zhang M; Cao C; Li X; Gu Q; Xu Y; Zhu Z; Xu D; Wei S; Chen H; Yang Y; Gao H; Yu L; Li J
Cancer Med; 2023 Jan; 12(2):2075-2088. PubMed ID: 35789544
[TBL] [Abstract][Full Text] [Related]
10. Tumor mutation burden as a biomarker in resected gastric cancer via its association with immune infiltration and hypoxia.
Wang D; Wang N; Li X; Chen X; Shen B; Zhu D; Zhu L; Xu Y; Yu Y; Shu Y
Gastric Cancer; 2021 Jul; 24(4):823-834. PubMed ID: 33687617
[TBL] [Abstract][Full Text] [Related]
11. Versican enrichment predicts poor prognosis and response to adjuvant therapy and immunotherapy in gastric cancer.
Song J; Wei R; Huo S; Liu C; Liu X
Front Immunol; 2022; 13():960570. PubMed ID: 36203562
[TBL] [Abstract][Full Text] [Related]
12. High expression of vinculin predicts poor prognosis and distant metastasis and associates with influencing tumor-associated NK cell infiltration and epithelial-mesenchymal transition in gastric cancer.
Li H; Wang C; Lan L; Behrens A; Tomaschko M; Ruiz J; Su Q; Zhao G; Yuan C; Xiao X; Li B; Yan L; Wu W; Li W; Chen J; He Y; Zhang C
Aging (Albany NY); 2021 Feb; 13(4):5197-5225. PubMed ID: 33535187
[TBL] [Abstract][Full Text] [Related]
13. The cancer-associated fibroblast-related signature predicts prognosis and indicates immune microenvironment infiltration in gastric cancer.
Mak TK; Li X; Huang H; Wu K; Huang Z; He Y; Zhang C
Front Immunol; 2022; 13():951214. PubMed ID: 35967313
[TBL] [Abstract][Full Text] [Related]
14. A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Therapeutic Response of Gastric Cancer.
Xiao S; Liu X; Yuan L; Wang F
Front Cell Dev Biol; 2021; 9():736682. PubMed ID: 34926441
[No Abstract] [Full Text] [Related]
15. DZIP1 expressed in fibroblasts and tumor cells may affect immunosuppression and metastatic potential in gastric cancer.
Yin Y; Liu Y; Wang Y; Li J; Liang S; Zhang W; Ma Z; Liu S; Zou X
Int Immunopharmacol; 2023 Apr; 117():109886. PubMed ID: 36805200
[TBL] [Abstract][Full Text] [Related]
16. Identification and Validation of an Individualized EMT-Related Prognostic Risk Score Formula in Gastric Adenocarcinoma Patients.
Zhang D; Zhou S; Liu B
Biomed Res Int; 2020; 2020():7082408. PubMed ID: 32309437
[TBL] [Abstract][Full Text] [Related]
17. Discovery and Validation of an Epithelial-Mesenchymal Transition-Based Signature in Gastric Cancer by Genomics and Prognosis Analysis.
Xu H; Wan H; Zhu M; Feng L; Zhang H; Su F
Biomed Res Int; 2021; 2021():9026918. PubMed ID: 34746312
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of an immune signature associated with EMT and metabolic reprogramming for predicting prognosis and drug response in bladder cancer.
Zhang Z; Yu Y; Li P; Wang M; Jiao W; Liang Y; Niu H
Front Immunol; 2022; 13():954616. PubMed ID: 35958586
[TBL] [Abstract][Full Text] [Related]
19. Tumor purity as a prognosis and immunotherapy relevant feature in gastric cancer.
Gong Z; Zhang J; Guo W
Cancer Med; 2020 Dec; 9(23):9052-9063. PubMed ID: 33030278
[TBL] [Abstract][Full Text] [Related]
20. Fibroblastic galectin-1-fostered invasion and metastasis are mediated by TGF-β1-induced epithelial-mesenchymal transition in gastric cancer.
You X; Wu J; Zhao X; Jiang X; Tao W; Chen Z; Huang C; Zheng T; Shen X
Aging (Albany NY); 2021 Jul; 13(14):18464-18481. PubMed ID: 34260413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
